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4.1. Introduction
Up to now, four subtypes of human histamine receptors (HR)s have been identified: 
H1R, H2R, H3R, and H4R, all of them being GPCRs with seven transmembrane (TM)-
spanning helices, which are expressed on various cell types. 
The H1R is expressed upon various cell types including eosinophils (Simons 
& Akdis, 2009). This receptor plays a significant role in allergic inflammation 
and immune modulation, as it increases the release of histamine and other 
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mediators, chemotaxis of eosinophils and neutrophils, and enhances the 
antigen-presenting capacity and co-stimulatory activity of B cells. 
H2R has a key role in stimulating gastric acid secretion (Code, 2008; Hill et al., 
1997) while also posessing immunoregulatory effects (Akdis & Simons, 2006) 
and a role in allergic inflammatory responses by mediating mucus production 
in the airway, vasodilation, and bronchial smooth muscle relaxation (Parsons 
& Ganellin, 2006). Histamine via H2R differentially reduces fMLP
1-induced O2
− 
generation in neutrophils and eosinophils (Reher et al., 2012). Selective H2R 
antagonists (famotidin, tiotidine and zolantadine) reduce histamine-induced 
effects of induction of intracellular cAMP accumulation in neutrophils and 
eosinophils (Reher et al., 2012).
Classically H3R acts as a presynaptic auto-receptor that inhibits the 
synthesis and release of histamine in the histaminergic neurons in the central 
nervous system (CNS) (Martinez-Mir et al., 1990). H3R is also highly expressed 
in eosinophils, dendritic cells and monocytes (Simons & Akdis, 2009), while 
low amounts are expressed in the peripheral tissues (Hill et al., 1997). 
Activation of H3R inhibits adenylate cyclase, reduces production of cAMP and 
inhibits Ca2+ influx (Gaudy-Marqueste, 2010). Histamine through H3R may 
increase pruritus without the involvement of mast cells and also increase nasal 
congestion (Simons & Akdis, 2009). Selective agonists are in development for 
the disorders of central nervous system (Simons & Akdis, 2009). Chemotaxis 
of eosinophils via H3R was controversial (Raible et al., 1994); however, recent 
studies (see below) suggest that the newly described receptor, H4R, mediates 
this effect. 
The H4R is a relatively novel histamine receptor structurally and 
pharmacologically related to the H3R receptor (Liu et al., 2001). H4R is highly 
expressed in various cells of the immune system such as bone marrow and 
peripheral hematopoietic cells, eosinophils, mast cells, neutrophils, dendritic 
cells, T-cells and basophils (Parsons & Ganellin, 2006). H4R mediates the 
chemotaxis of mast cells and eosinophils in vivo. Histamine through H4R 
can increase calcium flux in human eosinophils (Simons & Akdis, 2009), and 
together with H2R it can increase the IL-16 release from the lymphocyte 
(Parsons & Ganellin, 2006). 
This chapter address the role of histamine and in particular that mediated 
by the H4R receptor in different immune cells involved in the innate response. 
The role and function of the cells are described followed by an examination of 
the effects of histamine on the cells. 
1 N-formyl-methionyl-leucyl-phenylalanine
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4.2. Mast cells and Basophils
Mast cells and basophils are considered to be major allergic effector cells and 
are generated from CD34+ stem cells, which are produced in the bone marrow 
(reviewed in Schroeder, 2011; Metcalfe, 2008; Falcone et al., 2011). Although 
both cell types share many morphological features and functions, basophils 
mature and are released into the blood from the bone marrow while mast cells 
arise from precursors that usually mature within tissues such as the skin, lung 
and gastrointestinal tract. Mast cells depend on stem cell factor (SCF), a cytokine 
produced by eosinophils, bone marrow endothelial cells and fibroblasts, for 
their survival, proliferation and maturation in vitro (Piliponsky et al., 2002). Mast 
cells are relatively large and their cytoplasm is highly granulated (Figure 4.1). 
These granules contain and release pharmacologically active compounds such 
as histamine, tryptase, chymase and proteoglycans (Galli et al., 2008). In humans, 
granules of tissue mast cells may contain either tryptase alone (found in lung 
alveoli, small intestinal mucosa and the mucosa in allergic eye disease) or tryptase 
together with mast cell-specific chymase, cathepsin G and carboxypeptidase A 
(mainly located in normal skin, blood vessels, the submucosa, and synovium) 
(Hsu & Boyce, 2009). A specific growth factor for basophils has not yet been 
discovered but they can be grown in vitro from CD34+ cells using IL-3, although 
in mice this cytokine exhibits some degree of redundancy since IL-3 knockout 
mice still produce some basophils (Lantz et al., 1998; Shen et al., 2008). 
4.2.1. Function 
Basophils migrate from the blood into tissues affected by allergic inflammation 
(reviewed in Falcone, Knol & Gibbs, 2011). These cells, along with their tissue-
fixed mast cell counterparts are major sources of histamine in humans, which 
Figure 4.1 Mast cells and eosinophil from the peritoneal lavage of CD48 knockout mice stained 
with Giemsa. Mast cells, full of granules are stained in violet color and one eosinophil on the top right 
corner is stained orange-purple. The key functions of the mast cells are written on the left and those 
of eosinophil on the right.
Bereitgestellt von | UZH Hauptbibliothek / Zentralbibliothek Zürich
Angemeldet
Heruntergeladen am | 19.10.17 08:38
Histamine H4 Receptor:
A Novel Drug Target in Immunoregulation and Inflammation
1 0 6 Chapter 4
is rapidly released upon allergen binding to antigen-specific IgE when bound 
to high affinity IgE receptors (FcεRI). Allergen-mediated activation of mast cells 
and basophils also results in the release of a large number of inflammatory 
mediators that govern the signs and symptoms of allergy. These include the 
release of eicosanoids (primarily PGD2 and LTC4, where mast cells release both 
and basophils release only LTC4) and various inflammatory cytokines. In humans, 
basophils are particularly prominent sources of the Th2-type cytokines IL-4 and 
IL-13, which cause IgE class switching in B cells leading to polyclonal IgE synthesis 
(Yanagihara et al., 1998) whereas mast cells generate IL-8 and TNF-α (Gibbs et al.,
2001). These cell types, therefore, not only contribute to the symptoms of 
acute allergic inflammation but also appear to play immunomodulatory roles 
in supporting pro-allergic immunity (particularly basophils) and inflammation 
associated with allergic disease. These cells also respond to infections with 
certain parasites and it is thought that their main biological function may be 
related to parasite expulsion (Falcone et al., 2001; Knight et al., 2008), although 
their exact biological roles are still poorly understood.
Mast cells together with dendritic cells are the first immune system cells that 
respond to and interact with antigens, invading pathogens or environmentally 
derived toxins. Mast cells can enhance host resistance by promoting clearance of 
bacteria during several bacterial infections (Kalesnikoff & Galli, 2008; Piliponsky 
et al., 2010; Thakurdas et al., 2007). FcεRI mediates important interactions 
between mast cells and bacteria. IgE antibodies against Staphylococcus aureus 
or its toxin have been found in patients suffering from atopic dermatitis 
(Bunikowski et al., 1999; Friedman et al., 1985; Motala, et al., 1986). These reports 
suggest that mast cells have an important role in bacterial infection. Mast cells 
are also thought to have some role in autoimmunity (Eller & Rosenkranz, 2012). 
New models are being developed for studying mast cell functions in vivo (Reber 
et al., 2012) to help understand their role in pathophysiology.
4.2.2.  Histamine and Other Biogenic Amines in Mast 
Cell Pathophysiology
Mast cells are the major histamine producers in humans (Schneider et al., 2010). 
As in other important histamine producing cells, such as histaminergic neurons 
and enterochromaffin-like cells (ECLC), the newly synthesized histamine is 
stored in specialized vesicles until a stimulus promotes exocytosis (Woska & 
Gillespie, 2012). The enzyme responsible for histamine synthesis, histidine 
decarboxylase (HDC, EC 4.4.4.22), is associated with the internal membrane of 
endoplasmic reticulum (ER) in its active form (Suzuki et al., 1998; Moya-García et 
al., 2005; Furuta et al., 2006). Thus, the first location of nascent histamine must 
be the ER lumen. From there, histamine is conducted to specialized granules. 
This raises the question of why histamine needs to be partitioned from the 
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other intracellular components. Histamine is a mono- or dication depending on 
the polarity of the environment, due to the presence of an imidazole moiety. 
Imidazole groups are often involved in acid/base catalytic reactions as well as 
in electrostatic binding to aromatic moieties of many different macromolecules 
with specific functional consequences (Pilbak, et al., 2012; Mutti et al., 2011). 
These chemical characteristics may explain why a cell producing large amounts 
of histamine has evolved to keep this reactive amine separate from other 
molecules in the cytoplasm. In addition to 5 membrane receptors (histamine 
receptors 1-4 and N-methyl aspartate receptor), histamine can bind to several 
types of ion transporters, members of Cytochrome P450 (Cyp) family, and 
nucleic acids (Ruiz-Chica et al., 2006; Schneider et al., 2010). 
An increase in free, newly synthesized histamine leads to a decrease in 
the cellular growth rate, as demonstrated in transfected cell cultures unable 
to store the amine in appropriate vesicles (Abrighach et al., 2010), where the 
G1/S transition is blocked in HEK cells transfected to express active HDC. 
This could explain the lack of stable transfected cell models overexpressing 
active mammalian HDC. These observations on transfected cultured cells are 
consistent with the fact that histamine is not actively produced by mast cell 
precursors during the first stages of mouse bone marrow cell differentiation 
in vitro, when more active cell proliferation occurs (García-Faroldi et al., 2009a). 
This suggests an antiproliferative role for newly synthesized free histamine in 
mammalian cells.  
Mast cell granules are mainly composed of several mast cell specific 
proteases (e.g. tryptase and chymase), peptidoglycans (e.g. serglycin), and 
biogenic amines. However, histamine is not the only biogenic amine present 
in mast cell granules. Some rodent mast cell subsets contain serotonin (the 
decarboxylation product of the HDC paralogue, the aromatic L-amino acid 
decarboxylase or dopa decarboxylase (DDC, EC 4.1.1.28) (Moya-García et al., 
2005). In addition, polyamines are essential for normal mast cell differentiation 
(García-Faroldi et al., 2010). The natural polyamines, putrescine, spermidine 
and spermine are ubiquitous aliphatic amines that have low molecular weight 
and are highly charged cations under physiological conditions. Putrescine is 
formed by decarboxylation of ornithine, a reaction catalysed by the enzyme 
ornithine decarboxylase (ODC, EC 4.1.1.17). Higher polyamines, spermidine and 
spermine, are synthesized by adding an aminopropyl group from decarboxylated 
S-adenosyl-methionine to putrescine and spermidine, respectively (Urdiales et 
al., 2001). Spermidine and spermine are polycations (3 and 4 positive charges at 
physiological pH) able to interact with anionic macromolecules, such as nucleic 
acids and proteoglycans (Belting et al., 2003; Poulin et al., 2012; Ruiz-Chica 
et al., 2001a-b and 2003), and other protein targets for histamine (e.g. NMDA 
receptor and CytP450) (Colwell & Levine, 1997; LaBella & Brandes, 2000). 
Taking into account these chemical and docking properties, it is not surprising 
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that polyamines contribute to the normal mast cell granule conformation as is 
the case for the other biogenic amines, histamine and serotonin (Ringvall et al.,
2008; Rönnberg et al., 2012). Thus, mast cells provide an excellent model to 
study the biochemical and physiological interplay among biogenic amines 
(Medina et al., 2005; Sánchez-Jiménez et al., 2007).
Higher polyamines are essential to maintain cell proliferation and viability 
(Kahana, 2009; Pegg, 2009). In contrast, excess of non-compartmentalized 
histamine can be an anti-proliferative factor (Abrighach et al., 2010). In addition, 
an excess of free polyamines can be deleterious as a source of reactive oxygen 
species and toxic aldehydes produced during their degradation (Babbar et al.,
2007). In mammalian cells, including mast cells, there are clear insights to 
indicate opposite activity patterns among the biosynthetic pathways of both 
histamine and polyamines (García-Faroldi et al., 2009b). Thus, histamine 
interferes with both ornithine and spermine uptake systems and is a negative 
non-direct modulator of ODC activity in mammalian cells (Abrighach et al., 2010; 
Fajardo et al., 2001a-b). These intertwined regulatory mechanisms are probably 
part of the molecular coordination of cell proliferation/differentiation programs 
in mammalian cells. In fact, in mouse bone marrow-derived mast cells, ODC is 
expressed and the highest spermidine and spermine levels are observed during 
the initial differentiation stages, in contrast to histamine concentrations (García-
Faroldi et al., 2009a).
The antiproliferative role of histamine, in agreement with the observation 
on transfected HDC overexpressing cells and both the HDC expression profile 
and histamine production during mast cell differentiation, is apparently in 
contrast with high HDC expression observed in mast-cell derived malignancies, 
such as mastocytosis. Valent’s group reported that human mastocytosis 
mast cells display increased expression of HDC and aberrant granules and 
proposed HDC as a marker of disease malignancy (Krauth et al., 2006). More 
recently, bone marrow cell hybridomas have also been obtained with high 
HDC expression (Kawahara, 2012). However, neoplastic cells have severe 
alterations of their signal transduction mechanisms (such as c-Kit in the case 
of the most aggressive forms of mastocytosis) (García-Montero et al., 2006), so 
the behaviour of transformed mast cells with respect to intracellular histamine 
signalling may be altered compared to normal cells. For instance, in chronic 
myeloid leukaemia, the oncoprotein BCR/ABL induces HDC expression; of 
course in these cells, functional properties of some important elements for cell 
life/death equilibrium are altered (Aichberger et al., 2006). Another possibility 
associating the survival of neoplastic cells with increased histamine production 
could be that the neoplastic histamine-producing cells would have higher or 
new capacities to “hidden” histamine with respect to their normal counterparts. 
This hypothesis should be pursued since transformed mast cells have altered 
granule morphologies and histamine (as well as polyamines) can bind to nucleic 
Bereitgestellt von | UZH Hauptbibliothek / Zentralbibliothek Zürich
Angemeldet
Heruntergeladen am | 19.10.17 08:38
Edited by Holger Stark
1 0 9Chapter 4
acids and has been located in cancer cell nuclei (Medina et al., 2008; Ruiz-Chica 
et al., 2006).
To our knowledge, there are no pharmacological methods to prevent 
histamine synthesis by mast cells. Two different inhibitors have been 
described as substrate analogues and their mechanisms of action have been 
characterized: monofluoromethyhistidine (alpha-FMH) and histidine methyl 
ester (HME) (Olmo et al., 2002; Rodríguez-Caso et al., 2003). However, neither 
can be used clinically. In contrast, the tea polyphenol epigallocatechin 3-gallate 
(EGCG) has been described as an inhibitor of HDC and DDC. EGCG can inhibit 
both paralogue enzymes by altering the environment of the cofactor and most 
probably occluding the catalytic site entrance for the substrate (Ruiz-Pérez et 
al., 2012). Consequently, these results could be the beginning for development 
of new preventive and/or therapeutic agents to be used, at least topically, for 
inflammatory pathologies where mast cell-derived biogenic amines could be 
an important part of the problem (e.g. prevention of atopic allergy reactions, 
atopic dermatitis, parasite infections, etc). The antitumourigenic and anti-
inflammatory properties described for EGCG (as an inhibitor of angiogenesis 
and NF-κB signalling) suggest that EGCG or its derivatives may be promising 
drugs against mastocytosis (Melgarejo et al., 2007, 2009 and 2010 a and b). 
Other rare diseases could also benefit from the development of new histamine 
synthesis modulators (Pino-Ángeles et al., 2012). 
An overview of the interactions between histamine, polyamines and various 
cell types is given in Figure 4.2. Histamine can have autocrine effects on mast 
cells usually via the H1R and H4R. Modulation of the activity of these receptors 
to discover new and more effective anti-inflammatory strategies is also an active 
field of R&D (Ohsawa & Hirasawa, 2012). It is the subject of other chapters/
subsections of this volume.
4.2.3. Action of Histamine on Mast Cells and Basophils 
In 1953, Riley & West reported for the first time that the major storage site of 
histamine in mammalian tissues was located in the mast cells (Riley & West, 
1953), usually in the cells’ secretory granules. Mast cells not only release 
histamine upon activation through FcεRI but also via other stimuli such as 
cytotoxic agents, polysaccharides, lectins, anaphylatoxins, calcium and many 
basic compounds (such as compound 48/80) (Lagunoff, Martin, & Read, 1983). 
Eosinophils can also activate the mast cells to release histamine (Piliponsky et al.,
1999). Histamine can act both in stimulatory and inhibitory ways on immune 
cells; it can enhance the antigen-presentation by dendritic cells, suppress TNF-α 
and IL-12 and increase IL-10 production by dendritic cells and monocytes (Hsu 
& Boyce, 2009). Recently, histamine has been reported to induce neuronal 
hypertrophy and increase the mast cell density in the gastrointestinal tract 
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(Keles et al., 2012). Histamine modulates cell events and plays an important 
role in immune modulation and allergic inflammation through histamine 
receptors (Table 4.1). Histamine acts through these receptors to mediate effects 
that include vasodilation and vasopermeability, smooth muscle contraction of 
bronchial and gastrointestinal tract, secretion of gastric acid, and induction of 
pruritus (Jutel, Blaser, & Akdis, 2005). 
Despite being the major producers and releasers of histamine, it has long 
been appreciated that mast cells and basophils are also affected by an autocrine 
action of the amine, which may play an important role in limiting their ability to 
further degranulate (Bourne et al., 1971; Lippert et al., 2004). However, owing 
to the difficulty in obtaining and purifying isolated primary human mast cells 
and basophils, a comprehensive analysis of HR expression (H1-4R) has not yet 
been completed in these cells. Despite this, much of the feedback inhibition in 
basophils and human skin mast cells is thought to be H2R-mediated (Lichtenstein 
& Gillespie 1973) although less is known regarding human lung mast cells 
or other mast cell types, which often display a marked degree of functional 
heterogeneity (Peters et al., 1982, MacGlashan, 2003). 
H2R agonists (such as impromidine) but not H1R agonists mimic the inhibitory 
actions of histamine on mast cells activated by compound 48/80 (an IgE-
independent stimulus) and are reversed by the H2R antagonist cimetidine (Masini 
et al., 1982). However, the H2R-mediated inhibitory actions of histamine caused 
by IgE-dependent activation, seem to be more prominent in basophils than 
mast cells (Kazimierczak et al., 1981; Summers et al., 1981; Peters et al., 1982). 
Recently, it was reported that this receptor is involved in the early suppression 
of basophils to release all known major mediator classes during venom-allergen 
immunotherapy (Novak et al., 2012). The mechanism responsible for H2R-
mediated inhibition of basophil activation is due to elevation of cyclic AMP and 
subsequent inhibition of extracellular calcium influx into these cells (Botana & 
MacGlashan, 1994; Lippert et al., 2004). 
Receptor Mast cell Eosinophil
H1R Activation ↑, IP3/[Ca
2+] ↑ Chemotaxis ↑
H2R Chemotaxis ↓
fMLPO2
- production ↓
IL-4 mediated inflammation ↑
H3R
Expressed in brain mast cell
Auto-receptor Chemotaxis ↑*
H4R
Chemotaxis ↑, cAMP ↑,
[Ca2+] mobilization
Cell shape change chemotaxis ↑,
CD11b ↑, CD54 ↑
* controversial, ↑ increase, ↓ decrease
Table 4.1 
Effects of histamine through its specific receptors on mast cells and eosinophils.
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H1R-antagonists also lead to increased intracellular cAMP generation due to 
competitive antagonism with H2R (Palacios et al., 1978; Lippert, et al., 2004) and 
some more recent generation H1R antagonists can reduce mast cell function 
(Levi-Schaffer, 2009). However, H1R expression in these mast cells and basophils 
is relatively low, although there is tentative evidence to suggest that it may be 
higher in immature mast cells (Lippert et al., 2004) and guinea pig basophils, 
where this receptor is involved in histidine uptake (Stewart & Kay, 1980). In a 
mouse model of allergen-induced pulmonary inflammation, H1R was found to 
have a key role in T cell chemotaxis (Bryce et al., 2006). It also increases the Th1 
type of cellular immune response and IFN-γ production. However, H1R decreased 
the IgE production (Simons & Akdis, 2009). 
Certain H1R antagonists such as terfenadine (but not cetirizine) can inhibit IgE-
dependent mediator release from basophils (Gibbs et al., 1998) but only at high 
concentrations (µM range) and it is unlikely that these effects are H1R specific. 
Nevertheless, new generation H1R antagonists are used as anti-allergic/mast cell 
stabilizing drugs due to their ability to inhibit mast cell activation (Levi-Schaffer 
& Eliashar, 2009), even though some of them might increase cellular cAMP in 
competitive antagonism with H2R. It has become increasingly apparent that 
species differences in histamine receptor isoforms may considerably impact on 
the agonist-antagonist pharmacology of various H1-4R modulating agents, their 
potency as well as their specificity to a particular HR type (Schnell et al., 2011; 
Seifert et al., 2003; Seifert et al., 2011).  
The H3R is expressed in brain mast cells but there have been conflicting 
reports regarding the actions of H3R modulators on peripheral tissue mast cells 
(Bissonnette, 1996; Nemmar et al., 1999; Rozniecki et al., 1999). In basophils, 
the H3R does not appear to affect function (Kleine-Tebbe et al., 1990; Tedeschi 
et al., 1991). These reports may reflect the problem associated with the 40% 
sequence homology of H3R with H4R (Liu et al., 2001; Morse et al., 2001) where 
agents such as α-methylhistamine (agonist) and thioperamide (antagonist) 
affect both receptor types. 
Lippert et al. showed that H3R is not expressed on human skin mast cells, in 
contrast to high levels of H4R expression (Lippert et al., 2004). Basophils also 
express H4R (Hofstra et al., 2003) but, as with human mast cells, there are no 
data at present to indicate a major role for this receptor in controlling mediator 
release from human mast cells and basophils. In mice, chemotaxis, intracellular 
calcium mobilization and LTB4 have been shown to be affected by H4R triggering, 
though degranulation and cAMP changes are not directly affected (Hofstra et 
al., 2003; Rosethorne & Charlton, 2011; Takeshita et al., 2003; Godot et al., 
2007). Even though H4R has not been shown to substantially affect mast cell 
and basophil mediator release, it is thought to play a role in effector cell (such 
as eosinophil) recruitment to tissues affected by chronic allergic inflammation 
(Hofstra et al., 2003). H4R was also shown to control human mast cell precursor 
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trafficking in the presence of CXCL12 (Godot, et al., 2007) and regulate the 
migration of mast cells and eosinophils into guinea pig airway epithelial tissue 
after allergen challenge (Yu et al., 2008). It would be of considerable interest if a 
reduction in mast cell numbers within tissues affected by allergic inflammation 
were demonstrated in humans due to a suppression of H4R-mediated trafficking 
of mast cells and their precursors, especially given the other properties H4R 
antagonists/inverse agonists on suppressing histamine-related itch (Ohsawa 
& Hirasawa, 2012). However, the species differences in HR isoforms and the 
pharmacological effects of various HR-modulating agents may be a major 
obstacle in the rapid development of new H4R–blocking drugs. 
4.3. Eosinophils
Eosinophils are blood-borne granulocytes that migrate into tissues in some 
physiological and pathological conditions where they survive for several days. 
Eosinophils are generated from myeloid progenitor cells in the bone marrow. 
The differentiation of myeloid progenitor cells into mature eosinophils requires 
critical transcription factors, namely GATA-12, PU.13 and C/EBP4 (McNagny & 
Graf, 2002; Nerlov & Graf, 1998; Nerlov et al., 1998). The development and 
proliferation of eosinophils is positively regulated by granulocyte-macrophage 
colony-stimulating factor (GM-CSF), as well as IL-3 and IL-5 cytokines (Lopez et 
al., 1986; Lopez et al., 1988; Rothenberg et al., 1988; Takatsu, Takaki, & Hitoshi, 
1994). Eosinophils consist of a characteristic bilobed nucleus and a cytoplasm 
enriched in secondary granules, which contain major basic protein (MBP), 
eosinophil peroxidase (EPO), eosinophil cationic protein (ECP) and eosinophil-
derived neurotoxin (EDN). These cationic proteins are cytotoxic molecules that 
play an important role in inflammation, allergy, parasitic infection, tissue injury 
and tumors. Eosinophil cytoplasm also contains other ‘granule’ types, namely: 
small granules, primary granules, lipid bodies and small secretory vesicles. 
Eosinophils respond to diverse stimuli by degranulating and releasing these 
cationic proteins, lipid mediators, cytokines, chemokines, and neuromodulators 
(Gleich & Adolphson, 1986). Eosinophils express various cell surface markers, 
such as Fc receptors, CCR3, PAF receptors, CD48, 2B4, Siglec-F and histamine 
receptors, which are responsible for cell-cell communication via various 
pathways. These receptors are grouped into adhesion molecules, cytokine 
2 A zinc family finger member
3 An ETS family member
4 CCAAT/enhancer-binding protein family
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receptors, immunoglobulin receptors and members of the immunoglobulin 
superfamily, chemotactic factors, enzymes, and molecules associated with 
apoptosis and cellular signalling (Rothenberg & Hogan, 2006).
4.3.1. Function of Eosinophils
Eosinophils have many functions (Figure 4.3) associated with the pathogenesis 
of various inflammatory diseases including parasitic helminth infections 
(Wardlaw & Moqbel, 1992;Weller, 1994), intestinal immunity (Hogan, Waddell, 
& Fulkerson, 2012), allergic diseases such as asthma, allergic rhinitis, atopic 
dermatitis, etc. (Weller, 2009) and they can function as antigen presenting 
cells (APCs) since they can both process and present a variety of microbial, 
viral, and parasitic antigens (Shi, 2004). Eosinophils secrete various cytokines 
capable of promoting T-cell proliferation, activation and Th1/Th2 polarization. 
Murine eosinophils promote the secretion of IL-4, IL-5 and IL-13 cytokines by 
Figure 4.3 Soluble and physical interactions between mast cells and eosinophils.
In this illustrative diagram, soluble interactions have been shown by boxed arrows with some 
of the key mediators secreted by mast cells and eosinophils responsible for mediating soluble 
interactions between them. At the centre, the allergic effector unit showing physical interaction 
between eosinophils and mast cells.
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CD4+ T-cells (MacKenzie et al., 2001). Human eosinophils also produce nerve 
growth factor (NGF), which is required for survival and functional maintenance 
of sympathetic neurons and also regulates immune responses (Solomon et al., 
1998). However the antigen presenting capacity of eosinophils is a controversial 
subject (van Rijt et al., 2003) as reviewed in (Rothenberg & Hogan, 2006). 
4.3.2. Action of Histamine on Eosinophils
Mast cells together with eosinophils, form “the allergic effector unit” (Figure 4.3), 
that is considered to be the basic functional unit of allergy. Eosinophils and mast 
cells communicate with each other in a bidirectional manner. This interaction 
is both physical through cell surface receptors such as CD48, 2B4 (Elishmereni 
et al., 2011; Minai-Fleminger et al., 2010) and/or soluble through various 
cytokines and chemokines (Minai-Fleminger & Levi-Schaffer, 2009) (Figure 4.3). 
Eosinophils can regulate mast cell function and vice versa. Eosinophil MBP can 
activate human umbilical cord blood–derived mast cells to release histamine, 
IL-8, GM-CSF, PGD-2, and TNF-α (Piliponsky et al., 2002). The mast cell protease 
chymase activates eosinophils and promotes the production of SCF. Eosinophil 
released NGF promotes mast cell survival and activation (Bullock & Johnson, 
1996; Horigome, Bullock, & Johnson, 1994). NGF also acts in an autocrine 
manner by activating the release of EPO (Solomon et al., 1998). EPO activates 
rat peritoneal mast cells to release histamine. The release of histamine occurs 
in a dose dependent manner upon incubation with MBP, EPO, and ECP (Zheutlin 
et al., 1984). Histamine can promote superoxide (O2
−) production in eosinophils 
which enhances the expression of C3b receptor and other membrane receptors 
(Pincus, DiNapoli, & Schooley, 1982). 
Overall, histamine influences eosinophil cell shape, upregulates the 
expression of adhesion molecules (CD11b and CD54) and induces chemotaxis 
(Ling et al., 2004). Histamine-induced eosinophil chemotaxis is blocked by 
the H4 receptor antagonist JNJ 7777120 and the H3/H4 receptor antagonist 
thioperamide, but not by H1 (diphenhydramine), H2 (ranitidine) or H3 receptor 
antagonists (Ling et al., 2004). Moreover, selective H1R- and H2R agonists do 
not mimic the effects of histamine. In contrast, H2R plays an inhibitory role in 
the activation of chemotaxis. Intriguingly, there is no inhibitory impact of H2R 
on the regulation of intracellular calcium Ca2+ concentrations, indicating that 
chemotaxis is regulated independently of rises in intracellular Ca2+ levels (Reher 
et al., 2012).
Synergy between histamine- and IL-4-mediated recruitment of eosinophils 
to the lung has been reported, as histamine is necessary to generate IL-4-
driven eosinophilic inflammation, mediated via H2R. Additionally, alveolar 
epithelial cells require H2R to produce CCL24, an eosinophil recruitment factor 
(Swartzendruber, Byrne, & Bryce, 2012). Allergic asthma was induced in the 
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histidine decarboxylase deficient mouse model and it was found that histamine 
positively controls eosinophilia (mediated by H4 receptor) but not bronchial 
hypersensitivity (Ohtsu, 2010). In a mouse model of asthma, H4R was found to 
influence the induction of Th2 responses by dendritic cells (Dunford et al., 2006) 
and may play a role in mediating pruritus (Dunford et al., 2007).
Based on these results, an effective treatment of allergy should be developed 
as a combinational therapy that targets not only H1R but the other receptors as 
well, especially H4R. This kind of therapy can interfere with both mast cells and 
eosinophils and reduce the overall allergic inflammation. 
4.4. Monocytes and Macrophages
The mononuclear phagocytic system is generated from committed haematopoietic 
stem cells located in the bone marrow (Murray & Wynn, 2011). Monocytes 
released from bone marrow into the circulation that can further differentiate 
into a range of tissue macrophages and dendritic cells (Fogg et al., 2006; Hume 
et al., 2002; Shi & Pamer, 2011). Bloodstream monocytes are subdivided into 
subsets that differ in size, trafficking and innate immune receptor expression 
and in their ability to differentiate following stimulation with cytokines and/or 
microbial molecules (Auffray et al., 2009; Geissmann et al., 2003). Monocytes 
mediate host antimicrobial defence (Serbina et al., 2008) and are also impli cated 
in many inflammatory diseases (Woollard & Geissmann, 2010). Although several 
subsets of monocytes and macrophages have been identified, the individual 
contribu tions of these subsets to health and disease are not well known, and it 
is probable that additional, functionally distinct subsets exist (Chow et al., 2011).
4.4.1. Function of Monocytes/Macrophages
When monocytes migrate from the circulation and extravasate through the 
endothelium, they differ entiate into macrophages or dendritic cells (Murray & 
Wynn, 2011). Thus, the primary role of monocytes is to replenish the pool of 
tissue-resident macrophages and dendritic cells in steady state and in response 
to inflammation. Monocytes, dendritic cells and macrophages, along with 
neutrophils and mast cells, are ‘professional’ phagocytic cells which express a 
multitude of receptors on their surfaces that detect signals that are not normally 
found in healthy tissues. An initial level of macrophage activation occurs when 
early warning signals trigger monocyte recruitment and in situ activation, or 
when IL-4 induces in situ macrophage proliferation (Jenkins et al., 2011). Tissue 
damage sensing is probably crucial at the second level of macrophage response, 
regardless of whether the damage is of a microbial nature. The mechanisms of 
tissue dam age sensing have been discussed in recent reviews (Chen & Nunez, 
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2010; Matzinger & Kamala, 2011). Beyond the initial activation and stimulation 
of mac rophages, cooperative actions of multiple sensors, feed forward cytokine 
networks and inter-organ com munication increase the output of monocytes 
and neutrophils driving inflammatory responses. Macrophage effectors work 
together in cell-intrinsic and cell-extrinsic networks (Nish & Medzhitov, 2011). 
For example, the production of interferon-γ (IFNγ) by T helper 1 (Th1) cells 
requires IL-12 production from activated mononuclear phagocytes, where IFNγ 
then stimulates macrophages to activate the antimicrobial mechanisms (Borden 
et al., 2007). 
The activation of mononuclear phago cytes leads to the generation of the 
superoxide anion radical and nitric oxide (NO) by NADPH oxidase as well as 
inducible nitric oxide synthase (iNOS), respectively (Ambrozova et al., 2010; 
Ambrozova et al., 2011). Both the superoxide anion radical and nitric oxide 
generate secondary reactive oxygen species (ROS) and reactive nitrogen 
species (RNS). Physiologically, ROS and RNS formation is one of the essential 
microbicidal mechanisms in the body. Although formation of reactive species is 
desirable for host defence, their overproduction can cause damage to the body’s 
own cells and tissue injury can contribute to the development of a number of 
serious diseases. Thus, the modulation of their production is an important target 
in the treatment of immune and inflammatory diseases (Lojek et al., 2008; Ren 
& Chung, 2007).
A key component of the macrophage response is also the production of anti-
inflammatory feed back mechanisms that encompass cell-intrinsic signalling 
feedback loops and cell-extrinsic mechanisms, such as the production of IL-10, 
which is an essential and non-redundant anti-inflammatory cytokine (Murray & 
Wynn, 2011). This part of macrophage response is the least clear and involves 
the final balance between chronic inflammation and re-establishment of 
homeostasis. The understanding of the underlying mechanisms that restore 
homeostasis after an inflammatory reaction underpins all research efforts 
related to chronic inflammatory diseases.
4.4.2. Action of Histamine on Monocytes/Macrophages
Histamine via H1R, H2R, H3R, and H4R has both proinflammatory or anti-
inflammatory effects, depending on the predominance of the types of histamine 
receptors (Tripathi et al., 2010) and histamine concentration. Histamine 
stimulates the release of proinflammatory cytokines and lysosomal enzymes 
from human macrophages.
Khan and Rai (Khan & Rai, 2007) reported that histamine differentially 
regulated the testicular macrophage immune responses in wall lizards. It 
inhibited phagocytosis and superoxide production at high concentrations (10-5 M)
while it stimulated superoxide production and did not affect phagocytosis at low 
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concentrations (10-10 M). Using selective H1R and H2R antagonists, pyrilamine 
and famotidine respectively, the H1R subtype was responsible for mediating 
the inhibitory effect of histamine on testicular macrophage immune responses 
at high concentrations, while H2R were involved in the stimulation at low 
concentrations. In contrast, Azuma and co-workers (Azuma et al., 2001) found 
that in vitro treatment of macrophages with histamine resulted in inhibition 
of chemotaxis and histamine at 10-5 M markedly inhibited the production of 
superoxide anions from both opsonized zymosan-A and phorbol 12-myristate 
13-acetate stimulated macrophages. Furthermore, histamine at a concentration 
range of 10-7 to 10-5 M significantly inhibited phagocytosis of Escherichia coli 
by macrophages. In addition, the H2R-selective agonist dimaprit resulted in 
inhibition of macrophage chemotaxis and markedly inhibited the production of 
superoxide anion by phorbol 12-myristate 13-acetate-stimulated macrophages 
and phagocytosis of E. coli by macrophages. In contrast, both histamine and 
dimaprit caused a concentration-dependent inhibition of lipopolysaccharide-
induced production of TNFα and IL-12 by macrophages. These results suggest 
that histamine and dimaprit may inhibit chemotaxis, phagocytosis, superoxide 
anion production and the production of TNFα and IL-12 by macrophages via the 
histamine H2R.
Monocytes and tissue macrophages exhibit different responses to histamine 
treatment, indicating that differentiation of monocytes to tissue macrophages 
might induce changes in the expression of H1R. Triggiani and co-workers 
(Triggiani et al., 2007) found that human lung macrophages had a higher 
expression of H1R mRNA and protein than monocytes. Moreover, they found 
high protein expression of H1R in monocyte-derived macrophages in contrast to 
the nearly undetectable expression of this protein in monocytes. Simultaneous 
analysis of H2R and H1R mRNA expression indicated that the H2R/H1R ratio is 
approximately 100-fold higher in monocytes in comparison with monocyte-
derived macrophages. Similarly, a shift from H2R to H1R during differentiation of 
histiocytic lymphoma cells U937 and human peripheral blood monocytes into 
macrophages was also reported (Wang et al., 2000). U937 cells are widely used 
as a model for monocytes. Differentiation of these cells increased H1R expression 
and decreased the H2R expression. These effects may be explained by the results 
of Murata and coworkers (Murata et al., 2005), who found H2R mRNA in U937 
cells is constitutively expressed and does not react to GM-CSF. In contrast, GM-
CSF increased mRNA expression for H1R. These U937 cells do not express H3R 
(Wang et al., 2000). Spontaneous and retinoic acid-induced differentiation of 
normal human monocytes and of leukemic THP-1 monocytes into macrophages 
results in a progressive loss of adenosine 3’,5’-cyclic monophosphate production 
induced by histamine via H2R (Mirossay et al., 1994). In THP-1 cells and in HL-60 
cells, retinoic acid treatment increased the abundance of mRNA expression of the 
H2R gene 4-fold, suggesting transcriptional control by a retinoic acid response 
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element. In THP-1 macrophages, histamine inhibited phorbol 12-myristate 
13-acetate-induced H2O2 formation via the activation of H2R. Expression of the 
H2R gene, histamine accumulation, and histidine decarboxylase activity were 
also demonstrated in normal human monocytes/macrophages and peripheral 
lymphocytes.
Vignola and coworkers (Vignola et al., 1994) found that histamine induced a 
significant increase in alveolar macrophages expressing the LFA-1, ICAM-1 and 
CD23b membrane markers and a significant increase in the release of fibronectin. 
The histamine effects were H1R specific, since they were significantly inhibited 
by an H1R antagonist pyrilamine. In contrast, Sirois and co-workers found that 
when alveolar macrophages from humans, Sprague Dawley rats and the rat 
alveolar macrophage cell line NR8383 were treated with histamine prior to their 
stimulation with lipopolysaccharide, histamine inhibited lipopolysaccharide-
stimulated TNF release in a dose-dependent manner (Sirois et al., 2000). This 
inhibition was mimicked by H2R and H3R agonists, but not by the H1R agonist 
betahistine. Furthermore, these authors reported the expression of H3R mRNA 
in human alveolar macrophages. Other authors (Morichika et al., 2003; Takahashi 
et al., 2002) found that histamine inhibited CD14, ICAM-1 and CD80 expression 
on human peripheral blood mononuclear cells induced by lipopolysaccharide 
and IL-18, respectively. TLR stimulation of monocytes is altered by histamine co-
incubation as secretion of pro-inflammatory cytokines such as TNFα, IL-12 and 
IL-18 is suppressed, while IL-10 secretion is enhanced. The modulatory effects of 
histamine on ICAM-1 expression and cytokine production were antagonized by 
the H2R antagonist famotidine but not by d-chlorpheniramine and thioperamide, 
and were mimicked by selective H2R agonists but not by H1R, H3R and H4R 
agonists, indicating the involvement of the H2R in the action of histamine 
(Takahashi et al., 2002, 2004; Morichika, et al., 2003). Monocytes stimulated by 
advanced glycation end products are known to up-regulate adhesion molecule 
expression but this effect is inhibited by the H2R (Zhang et al., 2010). Using THP-
1 cells, Tanimoto and colleagues (Tanimoto et al., 2001) showed that H1R and 
H2R mRNA were present in non-differentiated monocytic THP-1 cells, whereas 
in TPA-differentiated THP-1 macrophages, mRNA encoding for H1R, H2R and H4R 
(very low) was present. Nevertheless, the H1R and H2R mRNA were the most 
abundant. The monocytic THP-1 cells expressed higher amounts of H2R mRNA 
than H1R mRNA in comparison with differentiated THP-1 cells. 
Dijkstra and co-workers (Dijkstra et al., 2007) showed the expression of H4R in 
human monocytes obtained from peripheral blood by using flow cytometry. The 
expression of H4R was increased by IFN-γ. Histamine and H4R agonists (clobenpropit 
and 4-methylhistamine) induced calcium mobilization in monocytes. These 
effects were blocked by H4R antagonist JNJ7777120. In contrast, these agonists 
inhibited production of CCL2 by monocytes. Supernatants of H4R agonist-
stimulated monocytes attracted fewer monocytes in transmigration assays, 
Bereitgestellt von | UZH Hauptbibliothek / Zentralbibliothek Zürich
Angemeldet
Heruntergeladen am | 19.10.17 08:38
Histamine H4 Receptor:
A Novel Drug Target in Immunoregulation and Inflammation
1 2 0 Chapter 4
resulting in a reduction of monocyte recruitment. Damaj and colleagues (Damaj 
et al., 2007) described the protein expression of H4R in human monocytic cell 
lines THP-1, U937 and human peripheral blood monocytes using flow cytometry 
or immunoblot assays. Their results showed much lower expression of H4R in 
peripheral blood monocytes. Ohki and co-workers (Ohki et al., 2007) showed co-
expression of H4R with macrophage markers CD68 and CD163 in macrophage-
like cells from the human synovial tissues of patients with rheumatoid arthritis. 
Recently, Gschwandtner and colleagues (Gschwandtner et al., 2013) reported 
that several H4R agonists reduced the secretion of IL-12p70 from monocytes but 
the EC50 values were lower than those obtained with pharmacological assays. 
From the available data, it is clear that histamine modulates macrophage/
monocyte activity and their physiological/pathophysiological effects. It remains 
to be clarified which effects are receptor mediated and which histamine 
receptors are involved in histamine effects on macrophages.
4.5. Dendritic Cells
Dendritic cells are potent antigen-presenting cells that are present throughout 
the body and are central players in initiating and regulating innate and adaptive 
immune responses, particularly at mucosal sites. Dendritic cell survival, 
activation, maturation and polarization are largely influenced by local factors 
within their micro-environment such as microbial components, cytokines and 
metabolic products. Dendritic cells shape the functional polarization and 
differentiation of the reactive T-cells into Th1, Th2, Th9, Th17 and Treg responses 
by producing cytokines such as IL-12, IL-18, IL-23, IL-11, IL-10 or TGFß (Akdis et al.,
2011). The selection of an appropriate cytokine secretion pattern by dendritic 
cells is dependent on a number of factors, but is particularly influenced by the 
binding of microbial ligands, termed pathogen-associated molecular patterns 
(PAMPs), to pattern recognition receptors (PRRs) such as toll-like receptors (TLRs) 
and C-type lectin receptors (CLRs) (O’Mahony et al., 2006; Shilling et al., 2007). 
Dendritic cells are often found in close proximity to degranulated mast cells and 
can secrete histamine following activation under certain conditions. 
4.5.1. Action of Histamine on Dendritic Cells 
While dendritic cells have been shown to express H1R, H2R and H4R, it is not 
definitively established if the level of HR expression is altered during maturation 
or if different dendritic cell subsets (e.g. myeloid or plasmacytoid dendritic cells) 
preferentially up- or down-regulate individual HRs following specific micro-
environmental cues. Dendritic cells exposed to histamine have been shown to 
up-regulate their antigen-presenting capacity and Th1 polarization via the H1R 
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while activation of the H2R on dendritic cells preferentially drives IL-10 secretion 
and, under certain circumstances, promotes Th2 polarisation (Caron et al., 2001; 
Mazzoni et al., 2001; van der Pouw Kraan et al., 1998). H2R activation of human 
plasmacytoid dendritic cells leads to a significant down-regulation of IFNγ and 
TNFα secretion following CpG stimulation (Mazzoni et al., 2003). In addition, 
accumulation of plasmacytoid dendritic cells and CD11b+ dendritic cells, but not 
CD8+ dendritic cells, in draining lymph nodes is H2R dependent (Dawicki et al.,
2010). Furthermore, histamine reduces the production of NADPH-oxidase-
derived oxygen radicals by several types of myeloid cells, an effect mediated 
by the H2R (Hellstrand et al., 1994). However, Gschwandtner et al., (2011) found 
that human plasmacytoid dendritic cells from patients with psoriasis had high 
levels of the H4R compared to controls or those from atopic dermatitis patients. 
Histamine treatment reduced cytokine production from these cells and was 
more marked in those from patients with psoriasis. 
In contrast to other dendritic cell subsets, Langerhans cells within the 
epidermis seem to be regulated uniquely by histamine as they do not express 
H1R or H2R (Ohtani et al., 2003). However, Langerhans cells do express H4R 
and human inflammatory dendritic epidermal cells can express H4R following 
exposure to IFNγ, which results in the downregulation of CCL2 and IL-12 
secretion in an H4R-dependent mechanism (Gschwandtner et al., 2010; Dijkstra, 
et al., 2008). In contrast, murine studies suggest that inhibition of H4R on 
dendritic cells leads to decreased cytokine and chemokine production, which 
limits their ability to induce Th2 responses. Simon et al., 2011 found an increased 
antigen presentation capacity in dendritic cells from H4R
-/- mice. These mice 
had reduced mRNA expression of cytokines such as IFNγ and IL-10. Recently, 
dendritic cell H1R expression was shown to be required for IFNγ production by 
CD8 cells resulting in atopic dermatitis in a murine model (Vanbervliet et al., 
2011). Interestingly, IL-17+CD8 cells were induced by dendritic cells lacking H1R. 
Certain bacterial strains present within the human diet express the HDC gene 
and have been shown to release histamine (Coton et al., 2010). However, the 
in vivo homeostatic consequences of histamine release by these bacteria has 
not yet been determined, although it is likely that histamine-producing bacteria 
could impact the dendritic cell response to the bacteria itself and other bacterial 
strains through a bystander effect. 
Due to their potent ability to influence innate activation and adaptive 
polarization, dendritic cells are key cellular players in orchestrating protective 
and tolerogenic immune responses. Inappropriate dendritic cell PRR signalling 
has been associated with multiple inflammatory diseases, particularly those of 
tissues exposed to the external environment such as the gastrointestinal tract, the 
lungs and the skin. Histamine and its four receptors represent a complex system 
of immunoregulation with distinct dendritic cell effects dependent on receptor 
subtype expression (O’Mahony et al., 2011). Strategies that promote dendritic 
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cell H2R expression and activity could improve mucosal immuoregulatory 
activity and protect against allergic sensitization and inflammatory disorders.
4.6. Polymorphonuclear Neutrophils 
Polymorphonuclear neutrophils (or neutrophils) are the most abundant 
leukocytes in blood and constitute the first line of defence against bacteria 
and fungi. During episodes of infection, neutrophils leave the blood circulation 
and migrate to inflamed tissues (extravasation) where they clear the pathogens 
by a process called phagocytosis. The recruitment of neutrophils to sites of 
inflammation is a complex process orchestrated by soluble mediators (formyl 
peptides, chemokines, pro-inflammatory cytokines, complement split products) 
and adhesion receptors (selectins and β2 integrins) (Ley et al., 2007). The soluble 
mediators, which are produced during episodes of infection, induce expression 
of β2 integrins on the membrane surface of neutrophils (Sengeløv, 1993), the 
main adhesion receptors expressed in neutrophils. The soluble mediators also 
switch the β2 integrins from a low to a high affinity ligand binding conformation 
(inside-out signalling) (Diamond & Springer, 1993). This change of conformation 
in β2 integrins is required for strong attachment to the endothelium, migration 
along the endothelial layer and the subsequent transendothelial migration. In 
infected tissues, neutrophils migrate towards the pathogens and capture them. 
The capture of opsonised microorganisms primarily involves two receptors: the 
β2 integrins and the Fcγ receptors. The microoganisms are trapped inside the 
phagosome, which fuses with intracellular granules. The release of the granule 
content (proteases and anti-microbial peptides) into the phagosome, coupled 
with the production of reactive oxygen species, is responsible for the destruction 
of the microorganisms (Sheppard et al., 2005). 
4.6.1. Action of Histamine on Neutrophils
Histamine H1 binding sites are present in human neutrophils (Wescott & Kaliner, 
1983). [3H]pyrilamine, an H1R antagonist, binds human neutrophils in a specific, 
saturable and reversible fashion. Furthermore, the binding of [3H]pyrilamine is 
competed (by order of potency) by H1 antagonists, histamine, and H2 antagonists. 
It was estimated that human neutrophils express a large number of H1R (265 x 
103/cell) and have a homogeneous population of H1R, with a moderate affinity for 
histamine (KD = 52 nM). Another study reported presence of H2- but not H1-binding 
sites in neutrophils. A bioactive fluorescent derivative of histamine was shown to 
bind to the membrane surface of human neutrophils and histamine, cimetidine 
(an H2R antagonist) but not diphenhydramine (H1R antagonist) competed with the 
fluorescent derivative of histamine for binding sites (Petty & Francis, 1986). 
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Little information is available regarding expression of histamine receptors in 
neutrophils. There is a lack of information regarding expression of H1R, H2R or H3R 
in neutrophils. There is controversy as to whether the H4R is present in human 
neutrophils. The mRNA encoding for H4R was found in human neutrophils (Oda 
et al., 2000; Zhu et al., 2001) and in HL-60 cells differentiated into granulocytes 
(Van Rijn et al., 2006). However, other investigators did not detect the H4R 
messenger RNA in neutrophils (Ling et al., 2004). 
There is consistent support for a role of histamine in the inhibition of 
antimicrobial functions of human neutrophils. Histamine inhibits neutrophil 
degranulation induced by the potent chemoattractant fMLP (Seligmann et al., 
1983; Burde et al., 1989) or by zymosan particles (Busse & Sosman, 1976). 
Histamine also blunts fMLP-induced superoxide production in neutrophils 
(Seligmann et al., 1983; Burde et al., 1989). These effects of histamine are mediated 
by H2R but not by H1R. Indeed, antagonists of H2R such as metiamide (Busse & 
Sosman, 1976), cimetidine (Seligmann et al., 1983), ranitidine (Zimmerman & 
Millard, 1989) and famotidine (Burde et al., 1989) prevented these inhibitory 
effects of histamine. In contrast, chlorpheniramine, an antagonist of the H1R did 
not prevent histamine blocking degranulation induced by zymosan particles 
(Busse & Sosman, 1976). Additional evidence for the involvement of H2R in 
the negative regulation of neutrophil functions is provided by studies showing 
that inhibition of neutrophil degranulation by histamine is also reproduced by 
guanidine-type H2-agonists structurally derived from impromidine (Burde et al., 
1989). The regulatory effect of the H2R on neutrophil functions may be mediated 
through activation of adenylyl cyclase and increased production of the second 
messenger cAMP (Burde et al., 1989; Busse & Sosman, 1976). It remains to 
be investigated whether the H4R plays a role in the regulation of neutrophil 
antimicrobial functions.
Neutrophils stimulated with fMLP synthesize and release leukotrienes which 
are potent chemoattractants for neutrophils. Furthermore, histamine blocks 
fMLP-induced production of leukotrienes (Flamand et al., 2004). It is therefore 
plausible that the ability of histamine to block neutrophil functions is due to 
reduced synthesis of potent activators of neutrophil functions. Based on the use 
of pharmacological antagonists of H2R (cimetidine, ranitidine, and tiotidine) and 
H4R (thioperamide), it has been shown that H2R but not H4R is involved in the 
inhibition of fMLP-induced biosynthesis of leukotrienes by histamine (Flamand et 
al., 2004). Histamine also has profound effects on the oxidative burst and release 
of reactive oxygen species from neutrophils; however, these observations could 
be considered controversial (for full discussion see: Cíž & Lojek, 2013).
In addition to its regulatory role of antimicrobial functions, histamine has been 
demonstrated to regulate neutrophil adhesion and chemotaxis. Histamine caused 
limited inhibition of fMLP-dependent chemotaxis while stimulating chemokinesis 
(Seligmann et al., 1983). The ability of histamine to prevent chemotaxis may be 
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explained by the fact that the vasoamine diminishes expression of β2 integrins 
on the membrane surface (Francis et al., 1991). In contrast, by using a mouse 
mast-cell-dependent model of zymosan-induced peritonitis, it was proposed 
that histamine, by acting on H4R, controls neutrophil chemotaxis. Indeed, the H4R 
antagonist A-940894 blocks neutrophil influx in the peritoneum (Strakhova et al., 
2009). However, the H4R may indirectly control neutrophil migration by regulating 
expression levels of chemoattactants and chemokines. 
Histamine could play a key role in the resolution of inflammation. Indeed, 
in response to engagement of the TLR 4 (which binds gram negative bacteria), 
neutrophils produce histamine (Smuda et al., 2011). When pathogens have been 
cleared, histamine could limit neutrophil degranulation and reactive oxygen 
species production in order to avoid tissue damage.
4.7. Conclusions
The role of histamine in allergic reactions is undisputed. However, our increasing 
knowledge about this mediator and its functions places it central stage in the 
orchestration of the innate immune response and leading to the adaptive response. 
Studies have been complicated because of the differences in the receptors 
between species. Cellular responses also vary depending on the original tissue 
from which the cells were isolated, which is of special relevance for mast cells. 
The movement of cells from the blood stream out into the tissues, airways or gut 
can also modulate the expression of receptors and receptor subtypes. Finally an 
area that has received less attention, the underlying disease state may also cause 
modifications to receptor expression and/or the response to stimuli. 
From the data presented above, further work is necessary to elucidate the 
different HRs on inflammatory cells such as basophils, mast cells and neutrophils. 
The complex interplay between the inflammatory cells also requires further study. 
Using novel compounds with actions at more than one histamine receptor will 
provide both interesting scientific knowledge and possibly better treatments. 
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